Therapeutiska

Therapeutiska is a Swedish pharmaceutical company that specializes in the development and manufacturing of generic and biosimilar medicines. Founded in 1999, the company is headquartered in Stockholm, Sweden, and operates globally with a presence in multiple countries. Therapeutiska's portfolio includes a wide range of therapeutic areas, such as oncology, immunology, and infectious diseases. The company is committed to providing affordable and accessible healthcare solutions, focusing on generic drugs that offer cost-effective alternatives to branded medicines. Therapeutiska's operations are structured around its core competencies in drug development, manufacturing, and supply chain management. The company adheres to stringent quality standards and regulatory requirements to ensure the safety and efficacy of its products. Therapeutiska collaborates with various stakeholders, including healthcare providers, patients, and regulatory authorities, to drive innovation and improve patient outcomes. The company's mission is to enhance healthcare accessibility by delivering high-quality, affordable medicines that address unmet medical needs. Therapeutiska's dedication to research and development, combined with its commitment to ethical practices, positions it as a key player in the global pharmaceutical industry.